All participants received treatment for at least 52 weeks, with a maximum treatment duration of 104 weeks or until the study was completed to collect and evaluate major adverse cardiovascular events (MACE)
Your GP may consider whether blood tests are appropriate based on your symptoms and clinical assessment
The article cites clinical trials reporting local reactions in 5 to 15 percent of participants, and describes them as typically mild and self-limited within 24 to 72 hours with no intervention required
Leg cramps or muscle spasms are not routinely reported as primary side effects
At 1 year, the group had a mean BMI of 27.9 kg/m 2 and had lost approximately 18.3% (95% CI, 13-23.6) of their body weight from baseline
Baci D, Bruno A, Bassani B, Tramacere M, Mortara L, Albini A, Noonan DM